Advertisement

Lymphangioleiomyomatosis revealed by 68Ga-NOTA-Evans Blue PET/CT

  • Guozhu Hou
  • Wenshuai Xu
  • Yuanyuan Jiang
  • Kai-Feng Xu
  • Xiaoyuan Chen
  • Fang Li
  • Wuying ChengEmail author
Image of the Month
  • 56 Downloads
Part of the following topical collections:
  1. Image of the month
  2. Image of the month

Notes

Funding information

This study was funded by the National Natural Sciences Foundation of China (No. 81371588, No. 81101074, No. 81570061), the National Key Research and Development Program of China (2016YFC0901502), and the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (2017-12M-2-001).

Compliance with ethical standards

The study was approved by the institutional review board of our hospital, and written informed consent for publication of this report was obtained from the patient.

This study was registered at clinicaltrials.gov (NCT02496013).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Zhang J, Lang L, Zhu Z, Li F, Niu G, Chen X. Clinical translation of an albumin-binding PET radiotracer 68Ga-NEB. J Nucl Med. 2015;56:1609–14.  https://doi.org/10.2967/jnumed.115.159640.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010;35:14–26.  https://doi.org/10.1183/09031936.00076209.CrossRefPubMedGoogle Scholar
  3. 3.
    Zhang W, Wu P, Li F, Tong G, Chen X, Zhu Z. Potential applications of using 68Ga-Evans Blue PET/CT in the evaluation of lymphatic disorder: preliminary observations. Clin Nucl Med. 2016;41:302–8.  https://doi.org/10.1097/rlu.0000000000001171.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  • Guozhu Hou
    • 1
    • 2
  • Wenshuai Xu
    • 3
  • Yuanyuan Jiang
    • 1
    • 2
  • Kai-Feng Xu
    • 3
  • Xiaoyuan Chen
    • 4
  • Fang Li
    • 1
    • 2
  • Wuying Cheng
    • 1
    • 2
    Email author
  1. 1.Department of Nuclear Medicine, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  2. 2.Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear MedicineBeijingChina
  3. 3.Department of Pulmonary and Critical Care Medicine, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  4. 4.Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and BioengineeringNational Institutes of HealthBethesdaUSA

Personalised recommendations